Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 7/20 | 0.57 |
| ▸ | HTR2B | P41595 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 2/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.47 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1128181 | 0.98 | RAB9A (0.62) | RAB9ANPC1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL14895871 | 0.96 | LMNA (0.57) | RAB9ANPC1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL26862272 | 0.92 | LMNA (0.60) | RAB9ANPC1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL23411036 | 0.86 | LMNA (0.49) | RAB9ANPC1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL29891587 | 0.86 | LMNA (0.49) | RAB9ANPC1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL3120801 | 0.86 | LMNA (0.55) | RAB9ANPC1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL373400 | 0.84 | MPO (0.54) | RAB9ANPC1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL26295449 | 0.84 | LMNA (0.53) | ALDH1A1LMNAHTR2BTHRBUSP2 | |
| SCHEMBL3196713 | 0.84 | LMNA (0.53) | RAB9ANPC1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL3196725 | 0.84 | LMNA (0.53) | RAB9ANPC1ALDH1A1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12258605-B2 | Alkane oxidation by modified hydroxylases | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2025-03-25 | — | — | US | disclosed |
| US-20220112524-A1 | ALKANE OXIDATION BY MODIFIED HYDROXYLASES | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2022-04-14 | — | — | US | disclosed |
| US-11214817-B2 | Alkane oxidation by modified hydroxylases | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2022-01-04 | — | — | US | disclosed |
| EP-3755383-B1 | TRICARBONYL COMPLEXES OF TRANSITION METALS WITH BENZO-HETEROCYCLIC DERIVATIVES OF THE CYCLOPENTADIENYL ANION | NATIONAL CENTER FOR SCIENT RESEARCH DEMOKRITOS (GR) | 2021-08-18 | — | — | EP | disclosed |
| US-20200399662-A1 | ALKANE OXIDATION BY MODIFIED HYDROXYLASES | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2020-12-24 | — | — | US | disclosed |
| US-10648006-B2 | Alkane oxidation by modified hydroxylases | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2020-05-12 | — | — | US | disclosed |
| WO-2019180200-A1 | TRICARBONYL COMPLEXES OF TRANSITION METALS WITH BENZO-HETEROCYCLIC DERIVATIVES OF THE CYCLOPENTADIENYL ANION | NATIONAL CENTRE FOR SCIENTIFIC RESEARCH "DEMOKRITOS" (GR) | 2019-09-26 | — | — | WO | disclosed |
| US-20180273983-A1 | ALKANE OXIDATION BY MODIFIED HYDROXYLASES | THE CALIFORNIA INSTITUTE OF TECHNOLOGY | 2018-09-27 | — | — | US | disclosed |
| US-9963720-B2 | Alkane oxidation by modified hydroxylases | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2018-05-08 | — | — | US | disclosed |
| US-20170183689-A1 | ALKANE OXIDATION BY MODIFIED HYDROXYLASES | THE CALIFORNIA INSTITUTE OF TECHNOLOGY | 2017-06-29 | — | — | US | disclosed |
| US-9404096-B2 | Alkane oxidation by modified hydroxylases | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2016-08-02 | — | — | US | disclosed |
| US-20160024482-A1 | ALKANE OXIDATION BY MODIFIED HYDROXYLASES | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2016-01-28 | — | — | US | disclosed |
| US-9074178-B2 | Alkane oxidation by modified hydroxylases | THE CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2015-07-07 | — | — | US | disclosed |
| US-20150004668-A1 | ALKANE OXIDATION BY MODIFIED HYDROXYLASES | THE CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2015-01-01 | — | — | US | disclosed |
| US-8715988-B2 | Alkane oxidation by modified hydroxylases | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2014-05-06 | — | — | US | disclosed |
| EP-2121907-A2 | ALKANE OXIDATION BY MODIFIED HYDROXYLASES | The California Institute of Technology (US) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008098198-A2 | ALKANE OXIDATION BY MODIFIED HYDROXYLASES | THE CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2008-08-14 | — | — | WO | disclosed |
| EP-1899471-A2 | ALKANE OXIDATION BY MODIFIED HYDROXYLASES | The California Institute of Technology (US) | 2008-03-19 | — | — | EP | disclosed |
| US-20080057577-A1 | Oxidoreductase which catalyzes conversion of alkanes to alcohol | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2008-03-06 | — | — | US | disclosed |
| WO-2006105082-A2 | ALKANE OXIDATION BY MODIFIED HYDROXYLASES | THE CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2006-10-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080057577-A1 | Oxidoreductase which catalyzes conversion of alkanes to alcohol | ADH5, ADH1C, ADH1A | RAB9A 4172/4885NPC1 3430/4885ALDH1A1 22/4885 |
| US-20220112524-A1 | ALKANE OXIDATION BY MODIFIED HYDROXYLASES | ALKBH3, ALKBH2, EGLN3 | RAB9A 4237/4885NPC1 2279/4885ALDH1A1 44/4885 |
| US-20200399662-A1 | ALKANE OXIDATION BY MODIFIED HYDROXYLASES | ALKBH3, ALKBH2, EGLN3 | RAB9A 4237/4885NPC1 2279/4885ALDH1A1 44/4885 |
| US-12258605-B2 | Alkane oxidation by modified hydroxylases | ALKBH3, ALKBH2, EGLN3 | RAB9A 4237/4885NPC1 2279/4885ALDH1A1 44/4885 |
| US-11214817-B2 | Alkane oxidation by modified hydroxylases | ALKBH3, ALKBH2, EGLN3 | RAB9A 4237/4885NPC1 2279/4885ALDH1A1 44/4885 |
| US-10648006-B2 | Alkane oxidation by modified hydroxylases | ALKBH3, ALKBH2, EGLN3 | RAB9A 4237/4885NPC1 2279/4885ALDH1A1 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.